MarketLens

Why is Johnson & Johnson Selling its Orthopedics Unit

7 months ago

SHARE THIS ON:

Why is Johnson & Johnson Selling its Orthopedics Unit

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Is Johnson & Johnson's $1 Billion Cell Therapy Investment a Game Changer

Is Johnson & Johnson's $1 Billion Cell Therapy Investment a Game Changer

8 months ago

Johnson & Johnson's "New Era" of Growth: Why the Market Underestimates Its Innovative Pipeline

Johnson & Johnson's "New Era" of Growth: Why the Market Underestimates Its Innovative Pipeline

3 months ago

What's Driving Johnson Controls' Recent Momentum Ahead of Q2 Earnings

What's Driving Johnson Controls' Recent Momentum Ahead of Q2 Earnings

6 months ago

What Does Honeywell's Amended Deal for Johnson Matthey's Catalyst Business Signify

What Does Honeywell's Amended Deal for Johnson Matthey's Catalyst Business Signify

7 months ago

Category

Top Featured Pro Only Stock Analysis Investment Ideas ETFs Crypto

You may also like

Stock News•2 days ago

Why Did J&J Stock Fall After Q3 Earnings Despite Raised Guidance?

Johnson & Johnson shares fell 5.8% after Q3 results despite an earnings beat and raised guidance, as MedTech weakness, drug sales shortfalls and acquisition costs weighed on results.

Stock News•3 days ago

J&J Is Leaning Toward Spinning Out Its Hips-And-Knees Business

Johnson & Johnson is leaning toward spinning out its hips-and-knees business, CFO Joseph Wolk said, after previously exploring a separation of the unit.

Stock News•1 months ago

Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage

Johnson & Johnson's MedTech segment is delivering growth at the high end of its 5%–7% operational market-growth range for 2022–2027, driven by a shift toward cardiovascular products and continued inve...

Breaking News

Convertible Bonds

Debt/Share Issuance

Dividend Announcements

Forward Guidance Revisions

Guidance Updates

Valuation Multiples

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

2 months ago

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

2 months ago

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

2 months ago

Top Headlines

Stock News•57 minutes ago

Amazon's new Bee AI devices have a bystander problem, says former AWS security engineer

Stock News•1 hour ago

Here's Why ServiceNow (NOW) Fell More Than Broader Market

Stock News•1 hour ago

Salesforce (CRM) Suffers a Larger Drop Than the General Market: Key Insights

Stock News•1 hour ago

1 Obvious Metric That Makes Nvidia a Top Stock to Buy Now

Stock News•1 hour ago

S&P 500 Snapshot: Stocks Slide Nearly 2% for the Week